Judith Klimovsky V serves as Executive at BELLICUM PHARMACEUTICALS, INC, where they oversee executive responsibilities. Since joining the company, Judith Klimovsky V has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 1, 2024 involved receiving (via award) 680 shares valued at $0.
Judith Klimovsky V currently holds 680 shares of BELLICUM PHARMACEUTICALS, INC (BLCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Judith Klimovsky V has been a net neutral trader of BLCM stock. They have purchased $0 and sold $0 worth of shares.
Judith Klimovsky V's most recent insider trade was on May 1, 2024, when they sold 680 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 1, 2022 | BLCM | $0 | Option Exercise | 35,082 | $N/A | Discretionary |
| Jan 4, 2022 | BLCM | $0 | Option Exercise | 566 | $N/A | Discretionary |
| Jan 4, 2022 | BLCM | $0 | Option Exercise | 14,036 | $N/A | Discretionary |